BioPharma Resources

Drug Trial Radar · NCT01601704

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR

Last checked: Nov 19, 2026Latest source record: Feb 27, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 8,910 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

8,910

Actual

Start

Jun 2012

Primary completion

Aug 2015

Study completion Aug 2015

Sponsor

Lead sponsor
Orexigen Therapeutics, IncIndustry
Sponsor type
Industry
First posted
May 18, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effects of NB relative to placebo on major adverse cardiovascular events (MACE) such as cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in overweight and obese subjects who are at a higher risk of having these events because they have diabetes and/or other cardiovascular risk factors.

Conditions

  • Obesity
  • Overweight

Interventions

  • NB32Drug

    Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.

  • PBODrug

    Placebo. Administered in addition to the weight management program.

  • Weight Management ProgramBehavioral

    A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With a Confirmed Occurrence of Major Adverse Cardiovascular Event (MACE)Time frame: Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up

Locations

224 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Birmingham, Alabama

  • Site not named

    Dothan, Alabama

  • Site not named

    Mobile, Alabama

  • Site not named

    Scottsboro, Alabama

  • Site not named

    Chandler, Arizona

  • Site not named

    Mesa, Arizona

  • Site not named

    Peoria, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Scottsdale, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Tuscson, Arizona

  • Site not named

    Little Rock, Arkansas

  • Site not named

    Anaheim, California

  • Site not named

    Carmichael, California

  • Site not named

    Escondido, California

  • Site not named

    Fresno, California

  • Site not named

    Harbor City, California

  • Site not named

    Huntington Beach, California

  • Site not named

    La Jolla, California

  • Site not named

    Lomita, California

  • Site not named

    Los Angeles, California

  • Site not named

    Paramount, California

  • Site not named

    Pasadena, California

  • Site not named

    Riverside, California

  • Site not named

    Sacramento, California

  • Site not named

    Santa Rosa, California

  • Site not named

    Spring Valley, California

  • Site not named

    Thousand Oaks, California

  • Site not named

    Torrance, California

  • Site not named

    West Hills, California

  • Site not named

    Colorado Springs, Colorado

  • Site not named

    Denver, Colorado

  • Site not named

    Golden, Colorado

  • Site not named

    Wheat Ridge, Colorado

  • Site not named

    Norwalk, Connecticut

  • Site not named

    Stamford, Connecticut

  • Site not named

    Wilmington, Delaware

  • Site not named

    Washington D.C., District of Columbia

  • Site not named

    Boynton Beach, Florida

  • Site not named

    Brooksville, Florida

Showing 40 of 224 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.